Suprax (cefixime) is a third-generation oral cephalosporin licensed for uncomplicated UTI, otitis media, pharyngitis, bronchitis and uncomplicated gonorrhoea, and multiple FDA-approved generic cefixime products now sit alongside it on the market.
Suprax (cefixime), now off-patent in the US, is a third-generation oral cephalosporin dosed once or twice daily without injection or reconstitution for anything beyond the suspension. M Care Exports is a merchant exporter: we source Suprax and FDA-approved generic cefixime through licensed Indian distribution and manufacturing channels and dispatch on quote, not from our own manufacturing.
Cefixime exporter and bulk supplier from India.
For hospital, wholesaler and tender-desk orders, M Care quotes cefixime against buyer specification: brand (Suprax) or generic, dosage form (tablet, capsule, chewable tablet or powder for oral suspension), strength mix (100 mg, 150 mg, 200 mg or 400 mg, or 100 mg/5 mL, 200 mg/5 mL and 500 mg/5 mL suspension) and destination-market regulatory documentation. Because cefixime sits on both the WHO adult and paediatric Essential Medicines Lists and features on enteric-fever and gonorrhoea treatment protocols across our GCC and African markets, we align CTD/eCTD or country-specific dossier paperwork to the destination regulator's requirements before we confirm a shipping date.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Third-generation cephalosporin; beta-lactam antibiotic, sourced and documented for export.
Cefixime is a third-generation cephalosporin, a beta-lactam antibiotic that inhibits bacterial cell-wall synthesis. It is dosed orally and needs no cold-chain handling as a solid or reconstituted-at-dispense suspension.
Suprax's FDA-labelled indications cover uncomplicated urinary tract infections, otitis media, pharyngitis and tonsillitis, acute bronchitis exacerbations of chronic bronchitis, and uncomplicated gonococcal infections of the cervix and urethra, in adults and paediatric patients from 6 months. Destination-country labelling may add or narrow indications, so buyers should check the licensed list their own regulator publishes; in South Asia and parts of Africa, cefixime is also used against enteric fever alongside azithromycin under national treatment guidelines rather than the US label.
Suprax is supplied as 400 mg film-coated tablets or capsules, 100 mg / 150 mg / 200 mg chewable tablets, and powder for oral suspension reconstituted to 100 mg/5 mL, 200 mg/5 mL or 500 mg/5 mL. It is a solid or extemporaneously-reconstituted oral dosage form stored at controlled room temperature, which keeps freight on standard ambient lanes rather than the validated cold-chain we run for biologics.
Active ingredient
cefixime (as trihydrate in tablet/capsule form). Third-generation cephalosporin; beta-lactam antibiotic.
Forms and strengths
100 mg chewable tablet; 150 mg chewable tablet; 200 mg chewable tablet; 400 mg film-coated tablet; 400 mg capsule; 100 mg/5 mL powder for oral suspension; 200 mg/5 mL powder for oral suspension; 500 mg/5 mL powder for oral suspension.
Indications
Oral third-generation cephalosporin indicated for uncomplicated urinary tract infections, otitis media, pharyngitis/tonsillitis, acute bronchitis exacerbations and uncomplicated gonococcal infections, with additional national-guideline use against enteric fever in South Asia and parts of Africa.
Administration
oral. Tablet, capsule, chewable tablet, or powder for oral suspension.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers for cefixime are mainly hospital and community pharmacy procurement teams treating UTI and respiratory infection caseloads, national and regional MoH tender desks running paediatric and STI treatment lists, licensed pharmaceutical wholesalers and importers, and NGO or public-health programmes supplying enteric-fever and gonorrhoea treatment in markets where local registration is in place.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on cefixime.
Adult cefixime is dosed at 400 mg daily, either as a single dose or split 200 mg every 12 hours; the single-dose 400 mg regimen also covers uncomplicated cervical or urethral gonorrhoea, though current CDC guidance now positions ceftriaxone 500 mg IM as first-line and reserves oral cefixime 800 mg as the alternative when ceftriaxone is unavailable, so confirm which regimen a tender specification is actually quoting against. Paediatric dosing from 6 months is weight-based: 8 mg/kg/day of the suspension, as a single dose or 4 mg/kg every 12 hours. The powder for oral suspension is reconstituted at the dispensing pharmacy with water to the labelled concentration and, once made up, is stable for 14 days refrigerated or at room temperature; counsel dispensing staff to shake well and discard after that window. No boxed warning applies to cefixime, but it carries the standard cephalosporin caution: anaphylactic reactions have been reported, cross-reactivity in penicillin-allergic patients runs up to roughly 10%, and Clostridioides difficile-associated diarrhoea should be considered in any patient presenting with diarrhoea during or after a course.
The documentation pack a regulator actually asks for.
As an oral solid or reconstituted-at-dispense suspension, cefixime travels on standard ambient-temperature logistics; the documentation buyers actually chase is registration and batch paperwork, not thermal validation. M Care compiles CoA and batch records per consignment, CDSCO export licensure and WHO-GMP sourcing evidence from the manufacturing partner, and destination-language pack inserts, alongside the import licence a receiving pharmacy or wholesaler already holds.
On the brand-versus-generic question, Suprax is off-patent in the US, and multiple FDA-approved generic cefixime products from different manufacturers are separately registered and marketed alongside it, so buyers genuinely have a brand-or-generic choice; M Care quotes either against the tender specification and destination-market registration status. Internationally, cefixime is sold under a fragmented set of local brand names rather than one dominant originator, so we confirm which brand or INN-only generic listing a given market's regulator recognises before we quote.
If your question is the route rather than the molecule, start with the licensed route for importing medicines from India and come back here for the product specifics.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside cefixime.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for cefixime.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Cefixime supply, the specific questions.
Does a generic version of Suprax exist?
Yes. Suprax is off-patent in the US and multiple FDA-approved generic cefixime products from different manufacturers are registered and marketed alongside it. Registration status for generic cefixime varies by destination country, so M Care checks local approval before quoting brand or generic against a specific tender.
What dosage forms of cefixime does M Care supply?
400 mg film-coated tablets or capsules, 100 mg, 150 mg and 200 mg chewable tablets, and powder for oral suspension reconstituted to 100 mg/5 mL, 200 mg/5 mL or 500 mg/5 mL. Tell us your buyer specification, brand or generic, and we quote the format and strength mix accordingly.
Is cefixime still first-line treatment for gonorrhoea?
Current CDC guidance positions ceftriaxone 500 mg IM as first-line for uncomplicated gonorrhoea, with oral cefixime 800 mg as the alternative when ceftriaxone is unavailable. Destination-country treatment guidelines vary, so check the protocol your tender or clinical programme is following before we pack an order against a specific indication.
Does cefixime need cold-chain shipping?
No. It is a solid oral dosage form, or a powder reconstituted at the dispensing pharmacy, stored at controlled room temperature, so it moves on standard ambient logistics rather than the validated cold-chain lanes we use for biologics and vaccines.
Is cefixime on the WHO Essential Medicines List?
Yes. Cefixime capsules or tablets (200 mg and 400 mg) and a powder for oral liquid (100 mg/5 mL) are listed on both the adult WHO Essential Medicines List and the WHO Essential Medicines List for Children, which supports its place on many MoH and NGO procurement formularies.
What documentation does M Care provide with a cefixime shipment?
Certificates of analysis and batch records per consignment, CDSCO export paperwork and WHO-GMP sourcing evidence from the manufacturing partner, and destination-language pack inserts, plus confirmation of your import licence status before dispatch.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-09-11.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.